中药复方临床证据整合的信息衰减及对策

Information attenuation in the integration of Chinese herbal compound clinical evidence and the countermeasure

中药复方是中医临床研究中的常见干预手段,近年来产生了较多中药复方相关的系统综述/Meta分析,但以中药复方作为干预措施的中医临床证据在应用目前循证医学常规研究方法进行整合的过程中会存在较大程度的信息衰减。笔者建议建立适用于循证评价的中药复方的分类原则和标准,建立中药复方临床证据报告规范及针对中药复方的临床证据评价体系,建立规范的中药复方临床证据整合研究路径,利用人工智能等技术开发辅助研究工具,以促进中药复方临床证据全面准确地整合与利用。

Chinese herbal compound(CHC) is a common intervention in clinical research of TCM. In recent years, there have been a lot of systematic reviews/Meta-analysis. However, the TCM clinical evidence which use CHC as the intervention would have a large degree of information attenuation in the process of integrating according to the current routine research methods of EBM. The authors suggest that we should establish the classification principle and standard of CHC, establish the standard of clinical evidence report and the evaluation system of CHC clinical evidence, establish the standard research path of CHC clinical evidence integration, and use artificial intelligence technology to develop auxiliary research tools, so as to promote the comprehensive and accurate integration and utilization of CHC clinical evidence.